Evaluation of Resources to
Support the Identification and Care of Children with Prenatal
Substance or Alcohol Exposure in the Child Welfare System
Revision of a currently approved collection
No
Regular
10/13/2023
Requested
Previously Approved
36 Months From Approved
04/30/2026
412
384
89
47
0
0
The Children’s Bureau (CB) in the
Administration on Children, Youth and Families (ACYF),
Administration for Children and Families (ACF), U.S. Department of
Health and Human Services (HHS) is partnering with the Centers for
Disease Control and Prevention to support child welfare agency
staff in the identification and support of children in the child
welfare system living with prenatal substance exposure (PSE),
including prenatal alcohol exposure (PAE). To this end, we are
developing a toolkit of resources that child welfare agencies can
use to: • Increase awareness, understanding, and knowledge of
PAE/PSE; and • Plan and implement internal and cross-system
processes, in partnership with key stakeholders, that help
identify, assess/evaluate/screen, share information about, and
provide care and support to children with prenatal exposure and
their families. The CB is undertaking a multi-stage evaluation
designed to understand the extent to which the toolkit is achieving
these intended outcomes. The following activities will contribute
to the evaluation: (1) usability testing and (2) a formative
evaluation. The second stage of the evaluation builds on the first
stage. Usability testing of the toolkit was conducted November
2022-March 2023 (under Formative Generic for Program Support OMB
#0970-0531, exp 9/30/25) to gather feedback from child welfare
staff in the field to determine the usability of toolkit modules
before the toolkit is finalized. Based upon usability testing
findings, an equity review was conducted and the toolkit has
undergone modifications based upon the findings. Data collection
for the formative evaluation was approved in April 2023 (OMB#
0970-0608, exp 4/30/26).
US Code:
42
USC 5105 Name of Law: Child Abuse Prevention and Treatment Act
Reauthorization Act
This is a request to add an
additional information collection to this study. Specifically, we
have added focus groups and estimate conducting these discussions
with up to 28 individuals.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.